Vasculitis & polymyalgia rheumatica

Epidemiology and clinical characteristics of polyarteritis nodosa in Japan: findings from a nationwide survey

Semin Arthritis RheumPublished Cross-sectional study

Authors' conclusion

This epidemiological study revealed the number and sex ratio of patients with PAN in Japan, along with their clinical characteristics. It also detailed the features of cutaneous arteritis.

Study context

Population
Patients with PAN treated at hospitals in Japan identified in the first nationwide epidemiological survey868 reported in first survey
Participants
547 patients
Outcome
Epidemiological and clinical characteristics of PAN
Methodological detailsnationwide survey, secondary questionnaire, randomly selected facilities
  • Nationwide survey
  • Secondary questionnaire
  • Randomly selected facilities

Main finding

As reported in the abstract

Male
233
Female
314
Male-to-female ratio
1:1.3
Mean age at diagnosis, years (± SD)
51.7 ± 17.6
Fever
43.4%
Skin involvement
82.4%
Joint/muscle involvement
51.6%
Oral GC prescribed
95.4%
Concomitant immunosuppressants
78.6%
AZA
59.3%
CYC
49.3%
Remission
91.2%
Relapse
47.8%

Observational data: associations, not effects.

Further findings

Risk factors for relapse

Skin involvement was a risk factor for relapse
Fever was associated with a lower risk of relapse

Cutaneous arteritis (met diagnostic criteria)

Proportion of the 547 patients
14.4%
Male-to-female ratio
1:3.9
Mean age at onset, years (± SD)
47.5 ± 14.5

Pediatric-onset PAN (onset at age 18 years or younger)

Patients
22
Male ratio (higher)
1.8:1
Higher frequency of fever and skin involvement

Original publication

Epidemiology and clinical characteristics of polyarteritis nodosa in Japan: findings from a nationwide survey. Semin Arthritis Rheum. Published 29 July 2026. doi:10.1016/j.semarthrit.2026.153049

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.